Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “email@example.com”, and happy to have you featured on our newsletter!
mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our apps and services beautifully combine diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved CYRAMZA® (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and have been treated with sorafenib.
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided a report today on the in vitro efficacy of Mino-Lok against various strains of Candida auris.
Pharmaceutical company Gilead says it will donate 2.4 million bottles of its HIV prevention drug to the Centers for Disease Control, That’s enough to protect 200,000 people from the disease for 11 years.
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "firstname.lastname@example.org".